Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy, Gökhan Keser, Pamir Atagündüz, et al.
Clinical Rheumatology (2020) Vol. 39, Iss. 7, pp. 2085-2094
Open Access | Times Cited: 768

Showing 1-25 of 768 citing articles:

Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19)
Bram van den Borst, Jeannette B. Peters, Monique Brink, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 5, pp. e1089-e1098
Open Access | Times Cited: 440
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
André Santa Cruz, Ana Mendes‐Frias, Ana Andrade Oliveira, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 316
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients
Apurva Hariharan, Abdul Rahman Hakeem, Subathra Radhakrishnan, et al.
Inflammopharmacology (2020) Vol. 29, Iss. 1, pp. 91-100
Open Access | Times Cited: 266
Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
Mary Kathryn Bohn, Alexandra Hall, Lusia Sepiashvili, et al.
Physiology (2020) Vol. 35, Iss. 5, pp. 288-301
Open Access | Times Cited: 250
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 601-621
Open Access | Times Cited: 250
Pathogenesis and treatment of cytokine storm in COVID-19
Mehmet Soy, Gökhan Keser, Pamir Atagündüz
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 372-389
Open Access | Times Cited: 229
Extracellular vesicles as tools and targets in therapy for diseases
Mudasir A. Kumar, Sadaf Khursheed Baba, Hana Q. Sadida, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 226
Severe COVID-19: NLRP3 Inflammasome Dysregulated
Daan F. van den Berg, Anje A. te Velde
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 207
Remdesivir and its antiviral activity against COVID-19: A systematic review
Andri Frediansyah, Firzan Nainu, Kuldeep Dhama, et al.
Clinical Epidemiology and Global Health (2020) Vol. 9, pp. 123-127
Open Access | Times Cited: 206
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options
Shalki Choudhary, Kajal Sharma, Om Silakari
Microbial Pathogenesis (2020) Vol. 150, pp. 104673-104673
Open Access | Times Cited: 194
Controlling Cytokine Storm Is Vital in COVID-19
Lu Tang, Zhinan Yin, Yu Hu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 170
Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
Sobia Noreen, Irsah Maqbool, Asadullah Madni
European Journal of Pharmacology (2021) Vol. 894, pp. 173854-173854
Open Access | Times Cited: 165
Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality
Yifan Que, Chao Hu, Kun Wan, et al.
International Reviews of Immunology (2021) Vol. 41, Iss. 2, pp. 217-230
Open Access | Times Cited: 137
Potential therapeutic options for COVID-19: an update on current evidence
Zahra Niknam, Ameneh Jafari, Ali Golchin, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 136
Flavonoids against the SARS-CoV-2 induced inflammatory storm
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111430-111430
Open Access | Times Cited: 133
Pulmonary fibrosis secondary to COVID-19: a narrative review
Suzana Érico Tanni, Alexandre Todorovic Fabro, André Luís Pereira de Albuquerque, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 6, pp. 791-803
Closed Access | Times Cited: 131
NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond
Yuanfeng Zhu, Xiaoli Chen, Xin Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 129
Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
Balasubramanian Ganesh, Thangarasu Rajakumar, Malathi Mathiyazhakan, et al.
Clinical Epidemiology and Global Health (2021) Vol. 10, pp. 100694-100694
Open Access | Times Cited: 117
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Narayanappa Amruta, Wesley H. Chastain, Meshi Paz, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 58, pp. 1-15
Open Access | Times Cited: 117
COVID-19 and the clinical course of rheumatic manifestations
Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
Clinical Rheumatology (2021) Vol. 40, Iss. 7, pp. 2611-2619
Open Access | Times Cited: 116
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Ren‐Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 103
Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF‐κB, JAK/STAT, and MAPK signaling pathways
Saeed Mohammadian Haftcheshmeh, Maliheh Abedi, Kazem Mashayekhi, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 3, pp. 1216-1230
Closed Access | Times Cited: 77
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 74
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy
Gian Marco Leone, Katia Mangano, Maria Cristina Petralia, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1630-1630
Open Access | Times Cited: 73
Clinical Significance and Diagnostic Utility of NLR, LMR, PLR and SII in the Course of COVID-19: A Literature Review
Jakub Wiktor Kosidło, Blanka Wolszczak-Biedrzycka, Joanna Matowicka-Karna, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 539-562
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top